DNA Sequencing Giant Illumina Joins Hunt for Autism Blood Test
Views - MIT Technology Review 2013-03-28
Summary:
Illumina will work with SynapDx’s to find a blood-test that could allow treatment to start earlier.
Massachusetts startup SynapDx announced on Wednesday that it will work with DNA sequencer manufacturer Illumina to develop early detection tools for autism spectrum disorders, according to a release.